Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Operating Margin (2024)

Compass Therapeutics' Operating Margin history spans 1 years, with the latest figure at 1770.0% for Q2 2024.

  • On a quarterly basis, Operating Margin changed N/A to 1770.0% in Q2 2024 year-over-year; TTM through Jun 2025 was 7981.76%, a 149541.0% decrease, with the full-year FY2024 number at 6661.76%, changed N/A from a year prior.
  • Operating Margin hit 1770.0% in Q2 2024 for Compass Therapeutics.
  • Over the last five years, Operating Margin for CMPX hit a ceiling of 1770.0% in Q2 2024 and a floor of 1770.0% in Q2 2024.